CHUK and non-small cell lung carcinoma: Moreover, we also provide evidence that IKKα’s mechanism of action as an NSCLC tumor suppressor can, at least in part, involve the control of hypoxia-inducible pathways required for the enhanced growth of tumors in vivo.